Inhalation Anesthesia Market by Applications (Induction, and Maintenance), Products (Sevoflurane, Isoflurane, and Desflurane), and Regions (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2021 – 2028
The global inhalation anesthesia market size is projected to expand at a significant CAGR during the forecast period, 2021–2028. The growth of the market is attributed to the increasing geriatric population suffering from cardiovascular, orthopedic, neurological, respiratory, cancer, spinal, gastrointestinal, and other diseases and disorders.
Inhalational anesthesia (IA) come to be the anesthetic of choice over Intravenous Anesthesia (IVA) in many healthcare practitioners because it aids to avoid extreme dosage and keeps autonomic functions of patients intact. These drugs are eradicated through lugs and body have lower chance of retention. Inhaled routes of drugs have limited addiction and tolerance level as compared to other substitute routes. IA is less costly than IVA and has a lower risk of dementia. Recently, number of surgical procedures are increasing which results growth in the inhalation anesthesia market. The rising number of orthopedic procedures include ligament repair and other soft tissue overhaul is propelling the daycare ambulatory surgeries growth which helps the market.
The anesthesia recycling market is anticipated to play important role in enhancing the market dynamics and competition. The anesthesia recycling market is growing significantly due to inhalation anesthetic’s environmental impact which is released from hospital environment into the atmosphere. Around 1% of global carbon dioxide is emitted from anesthetic gases which causes huge environmental damage. While using anesthetic gases, the major concern is that patient uses only 5% and rest of it which is around 95% is released into the atmosphere that results in contribution to global warming.
To deal the environmental effect of anesthetic gases, several new technologies are evolving for searching anesthetic gases from hospital vents and recycling them. Anesthesia reclamation LLC, and Deltasorb Technologies (Blue Zone Technology) developed the anesthesia recycling systems. Anesthetic Recapture System was developed by Anesthesia reclamation LLC in which waste anesthetics from the operating rooms are collected by cryogenic condensing system.
Market Trends, Drivers, Restraints, and Opportunities
- Increasing prevalence of disorders such as respiratory diseases, gastrointestinal disorders, and cancer is major factor responsible for the market expansion during the forecast period.
- Rising geriatric population, and growing number of surgical procedures across globe are projected to boost the market expansion.
- Rising research and development in healthcare, and technological and scientific advancements are estimated to fuel the market growth.
- Increasing demand of growing demand for a lesser duration of hospitalization, and growing accessibility to health services are expected to drive the growth of the market.
- Inhalation anesthetics’ side effects is key factor that hinder the market expansion during the forecast period.
- Lack of awareness among people and patent expiration are expected to hamper the market growth.
Scope of the Report
The report on the global inhalation anesthesia market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
|
Attributes |
Details |
|
Report Title |
Inhalation Anesthesia Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast |
|
Base Year |
2020 |
|
Historic Data |
2018–2019 |
|
Forecast Period |
2021–2028 |
|
Segmentation |
Applications (Induction, and Maintenance), Products (Sevoflurane, Isoflurane, and Desflurane) |
|
Regional Scope |
Asia Pacific, North America, Latin America, Europe, and Middle East & Africa |
|
Report Coverage |
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast |
|
Key Players Covered in the Report |
Halocarbon Products Corporation, Hikima Pharmaceuticals PLC, Lunan Pharmaceutical Group Co. Ltd., Piramal Enterprises Limited, Jiangsu Hengrui Medicine Co. Ltd., Fresenius Kabi AG, and AbbVie Inc. |
Market Segment Insights
Induction segment is anticipated to expand at a rapid CAGR
On the basis of applications, the inhalation anesthesia market is segmented into induction and maintenance. The maintenance segment is expected to hold a key share of the market during the forecast period due to its huge requirement of volume for faster induction and maintenance along with recovery from anesthesia.
However, the induction segment is expected to grow at a lucrative CAGR over the forecast period during the forecast period. Induction of anesthesia needs greater concentration of drugs as compared to maintenance of anesthesia. There are some factors responsible for influencing induction of anesthesia such as Minimum Alveolar Concentration (MAC), patient’s age, compatibility with other drugs, potency, blood/gas solubility, therapeutic index of drug, and rate of metabolism by kidney/liver. In central nervous system inhalation general anesthetic agents have mechanism of action that depends on blood and gas solubility and Minimum Alveolar Concentration (MAC) concentration of different drugs. Therefore, patients sensitive to anesthetic agents are supervised to evade recovery delays in anesthesia.
Sevoflurane segment is expected to hold a major share
Based on products, the inhalation anesthesia market is divided into sevoflurane, isoflurane, and desflurane. All these products are used in maintenance and induction of anesthesia during surgical products. Baxter Healthcare have all 3 products inside its portfolio and its only player. Piramal Healthcare and AbbVie Inc. have sevoflurane and isoflurane in their portfolio.
The sevoflurane segment is expected to account for a key share of the in the coming years due to its therapeutic advantages and low cost. Other two, desflurane and isoflurane are based on patient needs and the requirement for prolonged induction or maintenance of anesthesia. On the other hand, the isoflurane segment is anticipated to expand at a rapid pace during the forecast period due to sparing effect on cardiovascular function which makes it useful in the anesthetic management.
North America is expected to dominate the market
On the basis of regions, the inhalation anesthesia market is categorized as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. The market of North America is anticipated to expand at an impressive CAGR during the forecast period. The regional market growth can be attributed to rising prevalence of several chronic diseases and advanced healthcare facilities. The demand of surgical products is increasing which includes ambulatory surgery and inpatient surgery. These surgeries are in high demand in North America which is anticipated to fuel the regional growth.
However, the market of Asia Pacific is expected to exhibit a rapid growth rate in the coming years owing to incidence of chronic diseases and availability of healthcare insurance for masses. Moreover, growing population, and public and private healthcare expenditure are projected to boost the regional growth. The increasing medical tourism along with rising penetration of insurance coverage are expected to aid more people to choose surgical products. Development of ambulatory healthcare centers is anticipated to propel the rise in population in Asia Pacific hence, positively impacting the market.
2. Assumptions and Acronyms Used
3. Research Methodology
4. Inhalation Anesthesia Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Inhalation Anesthesia Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Inhalation Anesthesia Market - Supply Chain
4.5. Global Inhalation Anesthesia Market Forecast
4.5.1. Inhalation Anesthesia Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Inhalation Anesthesia Market Size (000’ Units) and Y-o-Y Growth
4.5.3. Inhalation Anesthesia Market Absolute $ Opportunity
5. Global Inhalation Anesthesia Market Analysis and Forecast by Types
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Types
5.2.2. Y-o-Y Growth Projections by Types
5.3. Inhalation Anesthesia Market Size and Volume Forecast by Types
5.3.1. Sevoflurane
5.3.2. Isoflurane
5.3.3. Desflurane
5.4. Absolute $ Opportunity Assessment by Types
5.5. Market Attractiveness/Growth Potential Analysis by Types
6. Global Inhalation Anesthesia Market Analysis and Forecast by Applications
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Applications
6.2.2. Y-o-Y Growth Projections by Applications
6.3. Inhalation Anesthesia Market Size and Volume Forecast by Applications
6.3.1. Induction
6.3.2. Maintenance
6.4. Absolute $ Opportunity Assessment by Applications
6.5. Market Attractiveness/Growth Potential Analysis by Applications
7. Global Inhalation Anesthesia Market Analysis and Forecast by Region
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Region
7.2.2. Y-o-Y Growth Projections by Region
7.3. Inhalation Anesthesia Market Size and Volume Forecast by Region
7.3.1. North America
7.3.2. Latin America
7.3.3. Europe
7.3.4. Asia Pacific
7.3.5. Middle East and Africa (MEA)
7.4. Absolute $ Opportunity Assessment by Region
7.5. Market Attractiveness/Growth Potential Analysis by Region
7.6. Global Inhalation Anesthesia Demand Share Forecast, 2019-2026
8. North America Inhalation Anesthesia Market Analysis and Forecast
8.1. Introduction
8.1.1. Basis Point Share (BPS) Analysis by Country
8.1.2. Y-o-Y Growth Projections by Country
8.2. North America Inhalation Anesthesia Market Size and Volume Forecast by Country
8.2.1. U.S.
8.2.2. Canada
8.3. Absolute $ Opportunity Assessment by Country
8.4. North America Inhalation Anesthesia Market Size and Volume Forecast by Types
8.4.1. Sevoflurane
8.4.2. Isoflurane
8.4.3. Desflurane
8.5. Basis Point Share (BPS) Analysis by Types
8.6. Y-o-Y Growth Projections by Types
8.7. North America Inhalation Anesthesia Market Size and Volume Forecast by Applications
8.7.1. Induction
8.7.2. Maintenance
8.8. Basis Point Share (BPS) Analysis by Applications
8.9. Y-o-Y Growth Projections by Applications
8.10. Market Attractiveness/Growth Potential Analysis
8.10.1. By Country
8.10.2. By Product Type
8.10.3. By Application
8.11. North America Inhalation Anesthesia Demand Share Forecast, 2019-2026
9. Latin America Inhalation Anesthesia Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.1.3. Latin America Average Pricing Analysis
9.2. Latin America Inhalation Anesthesia Market Size and Volume Forecast by Country
9.2.1. Brazil
9.2.2. Mexico
9.2.3. Rest of Latin America
9.3. Absolute $ Opportunity Assessment by Country
9.4. Latin America Inhalation Anesthesia Market Size and Volume Forecast by Types
9.4.1. Sevoflurane
9.4.2. Isoflurane
9.4.3. Desflurane
9.5. Basis Point Share (BPS) Analysis by Types
9.6. Y-o-Y Growth Projections by Types
9.7. Latin America Inhalation Anesthesia Market Size and Volume Forecast by Applications
9.7.1. Induction
9.7.2. Maintenance
9.8. Basis Point Share (BPS) Analysis by Applications
9.9. Y-o-Y Growth Projections by Applications
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.11. Latin America Inhalation Anesthesia Demand Share Forecast, 2019-2026
10. Europe Inhalation Anesthesia Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Europe Average Pricing Analysis
10.2. Europe Inhalation Anesthesia Market Size and Volume Forecast by Country
10.2.1. Germany
10.2.2. France
10.2.3. Italy
10.2.4. U.K.
10.2.5. Spain
10.2.6. Russia
10.2.7. Rest of Europe
10.3. Absolute $ Opportunity Assessment by Country
10.4. Europe Inhalation Anesthesia Market Size and Volume Forecast by Types
10.4.1. Sevoflurane
10.4.2. Isoflurane
10.4.3. Desflurane
10.5. Basis Point Share (BPS) Analysis by Types
10.6. Y-o-Y Growth Projections by Types
10.7. Europe Inhalation Anesthesia Market Size and Volume Forecast by Applications
10.7.1. Induction
10.7.2. Maintenance
10.8. Basis Point Share (BPS) Analysis by Applications
10.9. Y-o-Y Growth Projections by Applications
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.11. Europe Inhalation Anesthesia Demand Share Forecast, 2019-2026
11. Asia Pacific Inhalation Anesthesia Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Asia Pacific Average Pricing Analysis
11.2. Asia Pacific Inhalation Anesthesia Market Size and Volume Forecast by Country
11.2.1. China
11.2.2. Japan
11.2.3. South Korea
11.2.4. India
11.2.5. Australia
11.2.6. Rest of Asia Pacific (APAC)
11.3. Absolute $ Opportunity Assessment by Country
11.4. Asia Pacific Inhalation Anesthesia Market Size and Volume Forecast by Types
11.4.1. Sevoflurane
11.4.2. Isoflurane
11.4.3. Desflurane
11.5. Basis Point Share (BPS) Analysis by Types
11.6. Y-o-Y Growth Projections by Types
11.7. Asia Pacific Inhalation Anesthesia Market Size and Volume Forecast by Applications
11.7.1. Induction
11.7.2. Maintenance
11.8. Basis Point Share (BPS) Analysis by Applications
11.9. Y-o-Y Growth Projections by Applications
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.11. Asia Pacific Inhalation Anesthesia Demand Share Forecast, 2019-2026
12. Middle East & Africa Inhalation Anesthesia Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Middle East & Africa Average Pricing Analysis
12.2. Middle East & Africa Inhalation Anesthesia Market Size and Volume Forecast by Country
12.2.1. Saudi Arabia
12.2.2. South Africa
12.2.3. UAE
12.2.4. Rest of Middle East & Africa (MEA)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Middle East & Africa Inhalation Anesthesia Market Size and Volume Forecast by Types
12.4.1. Sevoflurane
12.4.2. Isoflurane
12.4.3. Desflurane
12.5. Basis Point Share (BPS) Analysis by Types
12.6. Y-o-Y Growth Projections by Types
12.7. Middle East & Africa Inhalation Anesthesia Market Size and Volume Forecast by Applications
12.7.1. Induction
12.7.2. Maintenance
12.8. Basis Point Share (BPS) Analysis by Applications
12.9. Y-o-Y Growth Projections by Applications
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.11. Middle East & Africa Inhalation Anesthesia Demand Share Forecast, 2019-2026
13. Competition Landscape
13.1. Global Inhalation Anesthesia Market: Market Share Analysis
13.2. Inhalation Anesthesia Distributors and Customers
13.3. Inhalation Anesthesia Market: Competitive Dashboard
13.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
13.4.1. Halocarbon Products Corporation
13.4.2. Hikima Pharmaceuticals PLC
13.4.3. Lunan Pharmaceutical Group Co. Ltd.
13.4.4. Piramal Enterprises Limited
13.4.5. Jiangsu Hengrui Medicine Co. Ltd.
13.4.6. Fresenius Kabi AG
13.4.7. AbbVie Inc.
The global inhalation anesthesia market has been segmented on the basis of
Applications
- Induction
- Maintenance
- Sevoflurane
- Isoflurane
- Desflurane
- Asia Pacific
- North America
- Latin America
- Europe
- Middle East & Africa
- Halocarbon Products Corporation
- Hikima Pharmaceuticals PLC
- Lunan Pharmaceutical Group Co. Ltd.
- Piramal Enterprises Limited
- Jiangsu Hengrui Medicine Co. Ltd.
- Fresenius Kabi AG
- AbbVie Inc.
Key players competing in the inhalation anesthesia market include Halocarbon Products Corporation, Hikima Pharmaceuticals PLC, Lunan Pharmaceutical Group Co. Ltd., Piramal Enterprises Limited, Jiangsu Hengrui Medicine Co. Ltd., Fresenius Kabi AG, and AbbVie Inc. Key players are implementing several business strategies such as mergers, acquisitions, partnerships, collaborations, capacity expansion, and product launches to increase their market shares.
Our Clients
Related Reports
Some other reports from this category!
